CAV1 and breast cancer: It was recently revealed that breast cancer cells-derived exosomal caveolin-1 (Cav-1) could promote ECM deposition in lung fibroblasts as well as inhibit the PTEN/CCL2/VEGF-A signaling pathway in lung macrophages, thus contributing to the PMN formation [272].